Pride Chigwedere's paper, Estimating the Lost Benefits of Antiretroviral Drug Use in South Africa, has generated coverage in the international press, including the BBC and UPI . The Times of South Africa ran an article titled, Mbeki ‘must account for 330,000 deaths.
Download a pdf of the paper.
![]()
Harvard World Media: International Health: Botswana
![]() |
![]() |
| Botswana
|
One Woman's Story |
The Harvard AIDS Initiative partners with Botswana government in epidemic response
"Ampheletse Medupe’s headaches just wouldn’t go away. Living in her small, neat home outside the African nation of Botswana’s capital, the mother of four kept on as best she could until sores broke out on her face. Finally, she visited a doctor." (continue reading)
Study abroad program brings undergraduates to Botswana
"While her classmates in Cambridge were shivering through a New England February, Sandy Bolm was sweltering in the heat of a Botswana summer, staring her future in the face in the labs of the Botswana-Harvard Partnership." (continue reading)
Dark days of the late 1990s have brightened
"Joseph Makhema, a research associate at the Harvard School of Public Health and director of the Botswana-Harvard Partnership, said the history of AIDS in Botswana can be divided into the period before and after the antiretroviral program called MASA." (continue reading)
![]()
Response to Nevirapine-Based Antiretroviral Therapy After Single-Dose Nevirapine
The paper, Response to Antiretroviral Therapy after a Single, Peripartum Dose of Nevirapine, published in The New England Journal of Medicine, on January 11, 2007 was covered by John Donnelly in The Boston Globe, ( "A Harvard study has found a way around one of the thorniest problems in preventing HIV transmission from mother to child during birth in poor countries." ) and Donald McNeil in The New York Times, ("The results are good news for poor women in Africa, Asia and Latin America . . .").